Sydney E. McDermottAssociateMcDermott Will & Emery Websitewww.mwe.comOrganization ProfileFull ProfileBlogwww.mwe.com/insightsConnectEmailTwitterLinkedIn202-756-8045 Professional Biography Sydney McDermott is a member of the Intellectual Property Practice Group. More Legal and Business Bylines From Sydney E. McDermott Pre-Markman Claim Construction Is OK, Within Limits - (Posted On Thursday, October 31, 2024) No Need to Call for Backup at the PTAB (Sometimes) - (Posted On Thursday, October 24, 2024) No Matter How You Slice and Dice It, Conclusory Evidence Can’t Support Entire Market Value Damages - (Posted On Thursday, October 10, 2024) When Can Same Claim Limitation Have Different Meanings? When It’s Functional, Of Course - (Posted On Thursday, September 26, 2024) Beware Equitable Doctrine of Issue Preclusion in Multiparty, Multivenue Patent Campaigns - (Posted On Thursday, August 01, 2024) Credibility at Issue? Court May Compel Party Representative to Appear in Person - (Posted On Thursday, July 25, 2024) How Close Are They? PTO Looking for “Significant Relationship” Between Sequential IPR Petitioners - (Posted On Thursday, May 09, 2024) Is Evidence of All Claimed Elements in Prior Art Enough? Not Without Motivation to Combine - (Posted On Thursday, April 04, 2024) Same Product in Different Packaging May Constitute Separate Market for Antitrust Purposes - (Posted On Thursday, March 28, 2024) Stay in the Know: Informational Message Is Not a Source Identifier - (Posted On Thursday, February 01, 2024) Current Legal Analysis China’s National Intellectual Property Administration Releases Statistical Data on Patent Licensing from 2019 – 2023 by: Aaron Wininger FTC Approves Final Order Against Seller of AI “Testimonial & Review” Service for Allegedly Providing Subscribers with Means to Generate Deceptive Reviews by: Richard B. Newman Cook County Employers: Time To Update Your Paid Leave Policies by: Alison B. Crane , Sarah J. Gasperini FTC Scrutinizing Healthcare Lead Generators and Marketers as Open Enrollment Begins by: Richard B. Newman Beltway Buzz, December 20, 2024 by: James J. Plunkett Final Regulations Released for Partnership Recourse Liabilities by: Kenneth C. Wang , Jared C. Kassan EPA Finalizes TSCA Risk Management Rules for PCE and TCE by: Mark N. Duvall , Ryan J. Carra The Legal and Economic Realities of Medicare Drug Pricing: Navigating Opportunities and Challenges by: Adam Herbst Upcoming Events Jan 8 2025 Whistleblower Protections: Navigating Health Care Employment & Labor Rights Jan 14 2025 What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2025 Jan 15 2025 Healthy AI Roundtable Chicago Jan 31 2025 Mass Actions: Bankruptcies, MDLs, Class Actions & Harrington v. Purdue Feb 26 2025 MCLE Triple Play Print
